Pfizer/Eisai TriAD Alzheimer's support program offers bi-monthly newsletter, toll-free helpline.
Executive Summary
PFIZER/EISAI "TriAD" ALZHEIMER's SUPPORT SERVICES PROGRAM includes a series of newsletters called Adaptations for Living for the caregiver and patient. Each newsletter has its own theme and has a "progressively stronger focus on caregiving," the clinician's TriAD sourcebook says. Pfizer and Eisai are co-marketing the Alzheimer's symptoms treatment Aricept (donepezil), which was approved Nov. 25 and began shipping to distributors in January ("The Pink Sheet" Dec. 2, 1996, p. 19).